269 related articles for article (PubMed ID: 11483834)
21. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza.
Nichol KL
Arch Intern Med; 2001 Mar; 161(5):749-59. PubMed ID: 11231710
[TBL] [Abstract][Full Text] [Related]
22. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
[TBL] [Abstract][Full Text] [Related]
23. Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients.
Wongsurakiat P; Lertakyamanee J; Maranetra KN; Jongriratanakul S; Sangkaew S
J Med Assoc Thai; 2003 Jun; 86(6):497-508. PubMed ID: 12924797
[TBL] [Abstract][Full Text] [Related]
24. Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence.
Postma MJ; Jansema P; van Genugten ML; Heijnen ML; Jager JC; de Jong-van den Berg LT
Drugs; 2002; 62(7):1013-24. PubMed ID: 11985488
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness and socio-economic aspects of childhood influenza vaccination.
Nichol KL
Vaccine; 2011 Oct; 29(43):7554-8. PubMed ID: 21820477
[TBL] [Abstract][Full Text] [Related]
26. Potential cost-effectiveness of annual influenza immunization for infants and toddlers: experience from Canada.
Skowronski DM; Woolcott JC; Tweed SA; Brunham RC; Marra F
Vaccine; 2006 May; 24(19):4222-32. PubMed ID: 16423432
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model.
Yang MC; Tan EC; Su JJ
Hum Vaccin Immunother; 2017 Jan; 13(1):81-89. PubMed ID: 27624648
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach.
Brogan AJ; Talbird SE; Davis AE; Thommes EW; Meier G
Hum Vaccin Immunother; 2017 Mar; 13(3):533-542. PubMed ID: 27780425
[TBL] [Abstract][Full Text] [Related]
29. Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany.
Damm O; Eichner M; Rose MA; Knuf M; Wutzler P; Liese JG; Krüger H; Greiner W
Eur J Health Econ; 2015 Jun; 16(5):471-88. PubMed ID: 24859492
[TBL] [Abstract][Full Text] [Related]
30. Cost Effectiveness of Influenza Vaccine for U.S. Children: Live Attenuated and Inactivated Influenza Vaccine.
Shim E; Brown ST; DePasse J; Nowalk MP; Raviotta JM; Smith KJ; Zimmerman RK
Am J Prev Med; 2016 Sep; 51(3):309-17. PubMed ID: 27079638
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of a Russian-backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double-blind, placebo-controlled trial.
Brooks WA; Zaman K; Lewis KD; Ortiz JR; Goswami D; Feser J; Sharmeen AT; Nahar K; Rahman M; Rahman MZ; Barin B; Yunus M; Fry AM; Bresee J; Azim T; Neuzil KM
Lancet Glob Health; 2016 Dec; 4(12):e946-e954. PubMed ID: 27746226
[TBL] [Abstract][Full Text] [Related]
32. Net Costs Due to Seasonal Influenza Vaccination--United States, 2005-2009.
Carias C; Reed C; Kim IK; Foppa IM; Biggerstaff M; Meltzer MI; Finelli L; Swerdlow DL
PLoS One; 2015; 10(7):e0132922. PubMed ID: 26230271
[TBL] [Abstract][Full Text] [Related]
33. Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children.
Belshe RB; Gruber WC
Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1947-51. PubMed ID: 11779396
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States.
Prosser LA; Lavelle TA; Fiore AE; Bridges CB; Reed C; Jain S; Dunham KM; Meltzer MI
PLoS One; 2011; 6(7):e22308. PubMed ID: 21829456
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom.
Thommes EW; Ismaila A; Chit A; Meier G; Bauch CT
BMC Infect Dis; 2015 Oct; 15():465. PubMed ID: 26503131
[TBL] [Abstract][Full Text] [Related]
36. Cost effectiveness of an inpatient influenza immunization assessment and delivery program for children with asthma.
Teufel RJ; Basco WT; Simpson KN
J Hosp Med; 2008 Mar; 3(2):134-41. PubMed ID: 18438789
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of influenza vaccine effectiveness in 2017-2018 influenza season based on community children cohort study].
Zhu JL; Lyu MZ; Luo SY; Chen GS; Pang ZF; Zhang GM; Wu XH
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 May; 41(5):747-752. PubMed ID: 32447919
[No Abstract] [Full Text] [Related]
38. Potential Cost-Effectiveness of an Influenza Vaccination Program Offering Microneedle Patch for Vaccine Delivery in Children.
Wong C; Jiang M; You JH
PLoS One; 2016; 11(12):e0169030. PubMed ID: 28006012
[TBL] [Abstract][Full Text] [Related]
39. The effectiveness of vaccination against influenza in healthy, working adults.
Nichol KL; Lind A; Margolis KL; Murdoch M; McFadden R; Hauge M; Magnan S; Drake M
N Engl J Med; 1995 Oct; 333(14):889-93. PubMed ID: 7666874
[TBL] [Abstract][Full Text] [Related]
40. Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine.
Nichol KL; Mallon KP; Mendelman PM
Vaccine; 2003 May; 21(17-18):2207-17. PubMed ID: 12706712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
